Patients at the health system will soon receive personalized specialty care, including side effect and adherence management, regular follow-ups, access to financial assistance, and free medication delivery.
Sharp’s deal with Shields Health Solutions will first focus on four disease states: hematology, oncology, rheumatology and cardiology, according to a Shields news release. The system’s three specialty hospitals are a women’s hospital, a substance use disorder treatment center and a behavioral hospital.
Shields is a Walgreens-owned business that has partnered with about 80 systems and hospitals in the U.S.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
